Venture capital-backed Dutch gene therapy company uniQure raised well above its original expectation in its listing on the Nasdaq, bagging $91.8m.
GP takes a minority stake in the IT service, while the management team remain on board
Existing investors E.Ventures and Heartcore also participate in the funding round
Transaction involves four remaining assets, including Genesys, eDreams and Asia Broadcast Satellite
Existing investors Velocity Capital, Industrifonden and Frumtak also participate